Advances in wound care最新文献

筛选
英文 中文
Chemotherapy-Mediated Complications of Wound Healing: An Understudied Side Effect. 化疗介导的伤口愈合并发症。这是未被充分研究的副作用。
IF 5.8 3区 医学
Advances in wound care Pub Date : 2024-04-01 Epub Date: 2024-02-14 DOI: 10.1089/wound.2023.0097
Paulina Słonimska, Paweł Sachadyn, Jacek Zieliński, Marcin Skrzypski, Michał Pikuła
{"title":"Chemotherapy-Mediated Complications of Wound Healing: An Understudied Side Effect.","authors":"Paulina Słonimska, Paweł Sachadyn, Jacek Zieliński, Marcin Skrzypski, Michał Pikuła","doi":"10.1089/wound.2023.0097","DOIUrl":"10.1089/wound.2023.0097","url":null,"abstract":"<p><p><b>Significance:</b> Chemotherapy is a primary method to treat cancer. While chemotherapeutic drugs are designed to target rapidly dividing cancer cells, they can also affect other cell types. In the case of dermal cells and macrophages involved in wound healing, cytotoxicity often leads to the development of chronic wounds. The situation becomes even more severe when chemotherapy is combined with surgical tumor excision. <b>Recent Advances:</b> Despite its significant impact on patients' recovery from surgery, the issue of delayed wound healing in individuals undergoing chemotherapy remains inadequately explored. <b>Critical Issues:</b> This review aims to analyze the harmful impact of chemotherapy on wound healing. The analysis showed that chemotherapy drugs could inhibit cellular metabolism, cell division, and angiogenesis and lead to nerve damage. They impede the migration of cells into the wound and reduce the production of extracellular matrix. At the molecular level, they interfere with replication, transcription, translation, and cell signaling. This work reviews skin problems that patients may experience during and after chemotherapy and demonstrates insights into the cellular and molecular mechanisms of these pathologies. <b>Future Directions:</b> In the future, the problem of impaired wound healing in patients treated with chemotherapy may be addressed by cell therapies like autologous keratinocyte transplantation, which has already proved effective in this case. Epigenetic intervention to mitigate the side effects of chemotherapy is also worth considering, but epigenetic consequences of chemotherapy on skin cells are largely unknown and should be investigated.</p>","PeriodicalId":7413,"journal":{"name":"Advances in wound care","volume":" ","pages":"187-199"},"PeriodicalIF":5.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10924052/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139110664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Avenanthramide and β-Glucan Therapeutics Accelerate Wound Healing Via Distinct and Nonoverlapping Mechanisms. 金刚烷胺和β-葡聚糖疗法通过不同且不重叠的机制加速伤口愈合
IF 5.8 3区 医学
Advances in wound care Pub Date : 2024-04-01 Epub Date: 2024-02-26 DOI: 10.1089/wound.2023.0050
Hudson C Kussie, William Hahn, Dharshan Sivaraj, Filiberto Quintero, Amelia Knochel, Abdelrahman M Alfsharif, Jonathan P Yasmeh, Katharina Fischer, Sultana Mojadidi, Andrew Hostler, Maia Granoski, Eamonn McKenna, Dominic Henn, Ben Litmanovich, Abigail A Miller, Delaney K Schurr, Vincent W Li, William W Li, Geoffrey C Gurtner, Kellen Chen
{"title":"Avenanthramide and β-Glucan Therapeutics Accelerate Wound Healing Via Distinct and Nonoverlapping Mechanisms.","authors":"Hudson C Kussie, William Hahn, Dharshan Sivaraj, Filiberto Quintero, Amelia Knochel, Abdelrahman M Alfsharif, Jonathan P Yasmeh, Katharina Fischer, Sultana Mojadidi, Andrew Hostler, Maia Granoski, Eamonn McKenna, Dominic Henn, Ben Litmanovich, Abigail A Miller, Delaney K Schurr, Vincent W Li, William W Li, Geoffrey C Gurtner, Kellen Chen","doi":"10.1089/wound.2023.0050","DOIUrl":"10.1089/wound.2023.0050","url":null,"abstract":"<p><p><b>Objective:</b> Given the significant economic, health care, and personal burden of acute and chronic wounds, we investigated the dose dependent wound healing mechanisms of two <i>Avena sativa</i> derived compounds: avenanthramide (AVN) and β-Glucan. <b>Approach:</b> We utilized a splinted excisional wound model that mimics human-like wound healing and performed subcutaneous AVN and β-Glucan injections in 15-week-old C57BL/6 mice. Histologic and immunohistochemical analysis was performed on the explanted scar tissue to assess changes in collagen architecture and cellular responses. <b>Results:</b> AVN and β-Glucan treatment provided therapeutic benefits at a 1% dose by weight in a phosphate-buffered saline vehicle, including accelerated healing time, beneficial cellular recruitment, and improved tissue architecture of healed scars. One percent AVN treatment promoted an extracellular matrix (ECM) architecture similar to unwounded skin, with shorter, more randomly aligned collagen fibers and reduced inflammatory cell presence in the healed tissue. One percent β-Glucan treatment promoted a tissue architecture characterized by long, thick bundles of collagen with increased blood vessel density. <b>Innovation:</b> AVN and β-Glucan have previously shown promise in promoting wound healing, although the therapeutic efficacies and mechanisms of these bioactive compounds remain incompletely understood. Furthermore, the healed ECM architecture of these wounds has not been characterized. <b>Conclusions:</b> AVN and β-Glucan accelerated wound closure compared to controls through distinct mechanisms. AVN-treated scars displayed a more regenerative tissue architecture with reduced inflammatory cell recruitment, while β-Glucan demonstrated increased angiogenesis with more highly aligned tissue architecture more indicative of fibrosis. A deeper understanding of the mechanisms driving healing in these two naturally derived therapeutics will be important for translation to human use.</p>","PeriodicalId":7413,"journal":{"name":"Advances in wound care","volume":" ","pages":"155-166"},"PeriodicalIF":5.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139650045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Performance of Ultrasonography for Diabetic Foot Osteomyelitis. 超声对糖尿病足骨髓炎的诊断价值。
IF 5.8 3区 医学
Advances in wound care Pub Date : 2024-04-01 Epub Date: 2023-12-20 DOI: 10.1089/wound.2023.0135
Mateo López-Moral, Marta García-Madrid, Raúl J Molines-Barroso, Yolanda García-Álvarez, Francisco J Álvaro-Afonso, José Luis Lázaro-Martínez
{"title":"Diagnostic Performance of Ultrasonography for Diabetic Foot Osteomyelitis.","authors":"Mateo López-Moral, Marta García-Madrid, Raúl J Molines-Barroso, Yolanda García-Álvarez, Francisco J Álvaro-Afonso, José Luis Lázaro-Martínez","doi":"10.1089/wound.2023.0135","DOIUrl":"10.1089/wound.2023.0135","url":null,"abstract":"<p><p><b>Objective:</b> This study aims to analyze the potential diagnostic capability of ultrasonography (US) in detecting diabetic foot osteomyelitis (DFO) in patients with diabetic foot ulcers (DFUs). <b>Approach:</b> A 1-year prospective study was conducted on 47 consecutive patients with active DFUs and suspicion of DFO at a specialized diabetic foot unit. The following ultrasonographic features were evaluated at baseline: (1) periosteal reaction; (2) periosteal elevation; (3) cortical disruption; (4) sequestrum; and (5) positive power Doppler. The primary outcome measure aimed to establish the effectiveness of ultrasonographic features compared with aseptic bone culture for diagnosing DFO. Receiver operating characteristic (ROC) curves were utilized to evaluate the diagnostic performance of ultrasonographic features. Sample size could not be determined as it is the first study to assess ultrasonographic features for the diagnosis of DFO. The research adhered to the guidelines for diagnostic accuracy studies (Standards for Reporting of Diagnostic Accuracy Studies [STARD] 2015). <b>Results:</b> All patients (<i>n</i> = 24) diagnosed with DFO exhibited positive power Doppler, resulting in a sensitivity (S) and specificity (SP) of 1 and an area under the curve (AUC) of 1 (<i>p</i> < 0.001 [1-1]). Cortical disruption was present in 23 patients (95.8%) with DFO, yielding an S of 0.93, SP of 1, and AUC of 0.96 (<i>p</i> < 0.001 [0.88-1]). <b>Innovation:</b> It validates the diagnostic value of US for DFO as it is the first and largest study of its kind to establish a clear reference standard to guide clinician decision-making. <b>Conclusion:</b> This study demonstrates the effectiveness of cortical disruption and positive power Doppler in assessing DFO through US.</p>","PeriodicalId":7413,"journal":{"name":"Advances in wound care","volume":" ","pages":"167-175"},"PeriodicalIF":5.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89716621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Split-Thickness Skin and Dermal Pixel Grafts Can Be Expanded up to 500 Times to Re-Epithelialize a Full-Thickness Burn Wound. 分层皮肤和真皮像素移植物可以扩展到500倍,以使全层烧伤伤口重新上皮化。
IF 5.8 3区 医学
Advances in wound care Pub Date : 2024-04-01 Epub Date: 2023-12-11 DOI: 10.1089/wound.2023.0020
Kristo Nuutila, Riyam Mistry, Michael Broomhead, Elof Eriksson
{"title":"Split-Thickness Skin and Dermal Pixel Grafts Can Be Expanded up to 500 Times to Re-Epithelialize a Full-Thickness Burn Wound.","authors":"Kristo Nuutila, Riyam Mistry, Michael Broomhead, Elof Eriksson","doi":"10.1089/wound.2023.0020","DOIUrl":"10.1089/wound.2023.0020","url":null,"abstract":"<p><p><b>Objective:</b> Autologous skin transplantation is limited by donor site availability for patients with extensive burns. The objective of this study was to demonstrate the feasibility and efficacy of split-thickness skin (STS) and dermal pixel grafts (PG) in the treatment of burns. <b>Approach:</b> The study was divided into three arms of validation, expansion, and combination that all followed the same study design. Sixteen deep partial-thickness burns were created on the dorsum of anesthetized pigs. Three days postinjury the burns were debrided and grafted with STS and dermal PGs. The PGs were prepared by harvesting two skin grafts (split-thickness skin graft [STSG] and dermal graft) from the same donor site going down in depth. The grafts were minced to 0.3 × 0.3 × 0.3 mm PGs and suspended in a small volume of hydrogel. Healing was monitored for 6, 10, 14, or 28 days. In the validation study the PGs at 1:2 expansion ratio were transplanted and compared with STSG and untreated controls. The expansion study investigated the maximum expansion potential of the PGs and the combination of the benefits of transplanting STS and dermal PGs together. <b>Results:</b> The validation study showed that when STS and dermal PGs were transplanted in a 1:2 ratio they fully re-epithelialized the wounds in 14 days. The expansion study demonstrated that using expansion ratios up to 1:500 the wounds were re-epithelialized by day 28. The combination study showed that there was no additional benefit to use STS and dermal PGs together. <b>Innovation:</b> Pixel grafting provides expansion ratios greater than conventional STSG. The possibility to harvest both STS and dermal PGs from the same donor area further reduces the need for healthy skin. <b>Conclusion:</b> STSG and dermal grafts can be minced to PGs with preserved viability and expanded up to 500 times to re-epithelialize a wound.</p>","PeriodicalId":7413,"journal":{"name":"Advances in wound care","volume":" ","pages":"176-186"},"PeriodicalIF":5.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Astrada et al. re: "A Novel Randomized Trial Protocol for Evaluating Wound Healing Interventions". 对阿斯特拉达信件的回复。
IF 4.9 3区 医学
Advances in wound care Pub Date : 2024-03-27 DOI: 10.1089/wound.2024.0042
Donna Clements, Keith Harding
{"title":"Response to Astrada et al. re: \"A Novel Randomized Trial Protocol for Evaluating Wound Healing Interventions\".","authors":"Donna Clements, Keith Harding","doi":"10.1089/wound.2024.0042","DOIUrl":"10.1089/wound.2024.0042","url":null,"abstract":"","PeriodicalId":7413,"journal":{"name":"Advances in wound care","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139929496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Negative Pressure Wound Therapy: Challenges, Novel Techniques, and Future Perspectives. 负压伤口疗法:挑战、新技术和未来展望。
IF 4.9 3区 医学
Advances in wound care Pub Date : 2024-03-27 DOI: 10.1089/wound.2023.0157
Corey Keenan, Noor Obaidi, Jamie Neelon, Irene Yau, Anders H Carlsson, Kristo Nuutila
{"title":"Negative Pressure Wound Therapy: Challenges, Novel Techniques, and Future Perspectives.","authors":"Corey Keenan, Noor Obaidi, Jamie Neelon, Irene Yau, Anders H Carlsson, Kristo Nuutila","doi":"10.1089/wound.2023.0157","DOIUrl":"10.1089/wound.2023.0157","url":null,"abstract":"<p><p><b>Significance:</b> Negative pressure wound therapy (NPWT) has been in practice for decades, proving its utility in many applications, ranging from acutely infected wounds to complex combat wounds and skin grafting. It has been routinely demonstrated that NPWT has superior wound healing outcomes compared with previous standard-of-care therapies. However, the technique involves some challenges related to each of the components that comprise the therapy. The purpose of this article is to highlight the challenges, introduce the recent advancements, and discuss about the future directions in NPWT systems. <b>Recent Advances:</b> New techniques and materials have been developed to improve the currently used NPWT systems with promising results when utilized with appropriate indications. Many advancements have been introduced in modes of negative pressure delivery, pumps, interface dressings, adhesive dressings, and tubing technology. <b>Critical Issues:</b> An optimal NPWT system would avoid the common problems such as failure to deliver negative pressure due to loss of an airtight seal or tissue ingrowth into the interface dressing causing painful dressing changes and bleeding. Other challenges include infection control and patient pain and discomfort that may contribute to noncompliance. <b>Future Directions:</b> Many studies have been performed to evaluate the optimal combination of settings and components in various wounds; however, there is still no clear \"best\" answer for many specific patient-wound scenarios. Novel and emerging tissue engineering and regenerative medicine approaches could potentially be utilized in the future NPWT systems and thus, this review will discuss some novel ideas for future considerations.</p>","PeriodicalId":7413,"journal":{"name":"Advances in wound care","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140027175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: "A Novel Randomized Trial Protocol for Evaluating Wound Healing Interventions" by Bull et al. 致编辑的信:对 Bull 等人撰写的《评估伤口愈合干预措施的新型随机试验协议》(PMID: 37526355)的批判性评价。
IF 4.9 3区 医学
Advances in wound care Pub Date : 2024-03-20 DOI: 10.1089/wound.2024.0001
Adam Astrada, Budi Mulyana, Ratna Dewi
{"title":"Re: \"A Novel Randomized Trial Protocol for Evaluating Wound Healing Interventions\" by Bull <i>et al</i>.","authors":"Adam Astrada, Budi Mulyana, Ratna Dewi","doi":"10.1089/wound.2024.0001","DOIUrl":"10.1089/wound.2024.0001","url":null,"abstract":"","PeriodicalId":7413,"journal":{"name":"Advances in wound care","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139929495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Morphine (10, 20 mg) in a Postoperative Dressing Used with Patients After Surgical Debridement of Burn Wounds: A Prospective, Double-Blinded, Randomized Controlled Trial. 烧伤创面清创术后患者使用的术后敷料中的吗啡(1020mg):一项前瞻性、双盲、随机、对照试验。
IF 5.8 3区 医学
Advances in wound care Pub Date : 2024-03-01 Epub Date: 2023-10-18 DOI: 10.1089/wound.2023.0037
Grzegorz Kowalski, Małgorzata Domagalska, Krzysztof Słowiński, Monika Grochowicka, Marcin Zawadzki, Sylwia Kropińska, Wojciech Leppert, Katarzyna Wieczorowska-Tobis
{"title":"Morphine (10, 20 mg) in a Postoperative Dressing Used with Patients After Surgical Debridement of Burn Wounds: A Prospective, Double-Blinded, Randomized Controlled Trial.","authors":"Grzegorz Kowalski, Małgorzata Domagalska, Krzysztof Słowiński, Monika Grochowicka, Marcin Zawadzki, Sylwia Kropińska, Wojciech Leppert, Katarzyna Wieczorowska-Tobis","doi":"10.1089/wound.2023.0037","DOIUrl":"10.1089/wound.2023.0037","url":null,"abstract":"<p><p><b>Objective:</b> This is the first clinical trial to evaluate the analgesic effect of 10 and 20 mg of morphine used in a postoperative dressing with patients after surgical debridement of burn wounds. <b>Approach:</b> In this randomized controlled trial, 20 adult patients with third-degree flame burns, who had undergone surgical debridement under general anesthesia, were randomly assigned to either group A, whose members were treated with a burn dressing that contained 10 mg of morphine, or group B, whose members were treated with a burn dressing that contained 20 mg of morphine; the dressing was also soaked with octenidine and phenoxyethanol in the case of both groups. The plasma morphine concentrations were measured 1, 2, 3, and 6 h after surgery, while the level of pain intensity was determined on the Numeric Pain Rating Scale (NRS), and the occurrence of side effects was observed. <b>Results:</b> The serum morphine concentration levels were very low, but statistically different between the two groups at all time points. The NRS value was similar in both groups at all time points (<i>p</i> > 0.05). Despite this, in group B, the NRS value was 0 in all patients in postoperative hours 1, 2, and 3. No adverse effect of morphine sulfate was observed in any patient. <b>Innovation:</b> This project is the first clinical study to have demonstrated that morphine administered in dressings in concentrations of 0.02-0.08 mg/mL significantly reduces the occurrence of pain. <b>Conclusion:</b> The use of morphine in dressings after surgical treatment of burn wounds is very effective when it comes to pain management and is safe for the patient.</p>","PeriodicalId":7413,"journal":{"name":"Advances in wound care","volume":" ","pages":"115-122"},"PeriodicalIF":5.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41118834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Switching from Galenic to Advanced Dressings or Vacuum Assisted Closure Therapy Can Improve Quality of Life of Patients with Chronic Non-Responsive Pressure Skin Ulcers: Preliminary Data with Italian Translation of WOUND-Q. 从加利尼换成高级敷料或真空辅助闭合疗法可改善慢性非反应性压力性皮肤溃疡患者的生活质量:WOUND-Q 意大利语翻译的初步数据。
IF 5.8 3区 医学
Advances in wound care Pub Date : 2024-03-01 Epub Date: 2023-09-04 DOI: 10.1089/wound.2022.0150
Giovanni Francesco Marangi, Carlo Mirra, Marco Gratteri, Annalisa Cogliandro, Rosa Salzillo, Francesco Segreto, Gaetano Federico, Fara Desiree Romano, Caterina Rossi, Paolo Persichetti
{"title":"Switching from Galenic to Advanced Dressings or Vacuum Assisted Closure Therapy Can Improve Quality of Life of Patients with Chronic Non-Responsive Pressure Skin Ulcers: Preliminary Data with Italian Translation of WOUND-Q.","authors":"Giovanni Francesco Marangi, Carlo Mirra, Marco Gratteri, Annalisa Cogliandro, Rosa Salzillo, Francesco Segreto, Gaetano Federico, Fara Desiree Romano, Caterina Rossi, Paolo Persichetti","doi":"10.1089/wound.2022.0150","DOIUrl":"10.1089/wound.2022.0150","url":null,"abstract":"<p><p><b>Objective:</b> A few studies have focused on the quality of life (QoL) of patients with chronic non-responsive pressure skin ulcers. The aim of this study was to assess how correct treatment (advanced wound care [AWC] dressings alone or vacuum assisted closure [VAC] therapy alone) changes the QoL of these patients. <b>Approach:</b> One hundred six patients with chronic non-responsive pressure skin ulcers, who had previously used galenic dressings, applied without proper therapeutic indication, were included in this study. We administered the WOUND-Q, at time 0 and after 1 month of appropriate therapy, to assess patient-reported outcome measures. Group 1 consisted of 30 patients treated with advanced dressings, Group 2: 22 patients treated with VAC therapy, and Group 3: 30 patients continuing conventional galenic dressings (Control group). Statistical analysis allowed us to analyze QoL changes over time and to compare WOUND-Q Group 1 and 2 deltas with those of Group 3. The study followed the STROBE statement. <b>Results and Innovation:</b> In all the scales evaluated (Assessment, Drainage, Smell, Life impact, Psychological, Social, Sleep and Dressing), there were significant improvements in mean values for Groups 1 and 2. Kruskal-Wallis tests with Dunn's multiple-comparisons tests and Brown-Forsythe and Welch Analysis of Variance tests demonstrated significant differences between deltas of Group 1 and Group 2 compared with those of Group 3 for most scales analyzed. <b>Conclusions:</b> Administration of the WOUND-Q demonstrated that the application of advanced dressings alone or VAC therapy alone positively affects the QoL of patients with chronic nonresponsive pressure wounds, in comparison with galenic dressings alone. The WOUND-Q has been shown to be a valid tool in studying changes in QoL of these patients.</p>","PeriodicalId":7413,"journal":{"name":"Advances in wound care","volume":" ","pages":"131-139"},"PeriodicalIF":5.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10147249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Evidence Map of Clinical Practice Guideline Recommendations and Quality on Venous Leg Ulcer. 腿部静脉性溃疡临床实践指南建议和质量的证据图。
IF 5.8 3区 医学
Advances in wound care Pub Date : 2024-03-01 Epub Date: 2023-12-07 DOI: 10.1089/wound.2023.0079
Ya-Bin Zhang, Xue-Mei Zhong, Shui-Yu Wang, Dan Ma, Rui Li
{"title":"An Evidence Map of Clinical Practice Guideline Recommendations and Quality on Venous Leg Ulcer.","authors":"Ya-Bin Zhang, Xue-Mei Zhong, Shui-Yu Wang, Dan Ma, Rui Li","doi":"10.1089/wound.2023.0079","DOIUrl":"10.1089/wound.2023.0079","url":null,"abstract":"<p><p><b>Significance:</b> Venous leg ulcers (VLUs) are the most common venous disease, mainly presenting as open skin lesions on the legs or feet and are an important concern in clinical care settings. <b>Recent Advances:</b> Comprehensive tactics were employed to search electronic databases PubMed, Embase, guideline databases, and society websites were searched for Clinical Practice Guidelines (CPGs) on VLU care. The basic information, recommendations for the VLUs, methodological quality, and reporting quality of VLU's CPGs were extracted and captured in Excel. The quality of each CPG was independently assessed by four researchers using AGREE II instrument and the RIGHT checklist. <b>Critical Issues:</b> This study included 19 CPGs with a combined 23 recommendations. The assessment of VLUs was summarized based on the recommendations of VLUs in 11 major items; six on VLU's diagnosis and six on therapeutic strategies of VLUs. The identified CPGs were of mixed quality, and the highest score based on the scope and purpose was 82.85 ± 11.66, whereas the lowest mean score based on the editorial independence by AGREE II was 59.93 ± 21.50. Regarding the RIGHT checklist, field one (basic information) had the highest reporting rate (84.33%), whereas field five (review and quality assurance) had the lowest quality of CPGs (41.11%). <b>Future Directions:</b> This evidence map provided new perspectives in the presentation of evidence. In addition, the evidence map collected and evaluated the characteristics of published CPGs. Thus, the evidence map enhances our knowledge and promotes the development of trustworthy CPGs for VLUs.</p>","PeriodicalId":7413,"journal":{"name":"Advances in wound care","volume":" ","pages":"140-152"},"PeriodicalIF":5.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41188119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信